American Renal Associates (ARA) Reports Q2 Loss of $0.75
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 14% on Q1 earnings beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
American Renal Associates Holdings, Inc. Announces Second Quarter 2016 Results
August 9, 2016 4:08 PM EDTBEVERLY, Mass.--(BUSINESS WIRE)-- American Renal Associates Holdings, Inc. (NYSE: ARA) (ARA or the Company), a leading provider of outpatient dialysis services, today announced financial and operating results for the second quarter ended June 30, 2016.
Certain metrics, including those expressed on an adjusted basis, are Non-GAAP financial measures (See Use of Non-GAAP Financial Measures and the reconciliation tables further below).
Second Quarter 2016 Highlights (all percentage changes compare Q2 2016 to Q2 2015 unless noted):
Net patient service operating revenues increased 15% to $185.6 million; Net income (loss) attributable to... More
